IGWM
NNVC icon

ICA Group Wealth Management’s NanoViricides NNVC Stock Holding History

ICA Group Wealth Management’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-200
Closed -$230 – 847
2023
Q2 		$230 Hold
200
– – ﹤0.01% 1288
2023
Q1 		$234 Hold
200
– – ﹤0.01% 1233
2022
Q4 		$283 Buy
+200
New +$312 ﹤0.01% 1267

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

ICA Group Wealth Management's NNVC Position: Q3 2023 in Review

ICA Group Wealth Management sold out of NanoViricides (NNVC) in Q3 2023, closing a stake of 200 shares — an estimated $230 sold.

ICA Group Wealth Management first reported a position in NNVC in Q4 2022 and held it in 3 quarters. The position peaked at $283 in Q4 2022. 30 funds tracked by Wall St. Rank hold NNVC as of Q3 2023.

  • ICA Group Wealth Management reported no remaining NanoViricides position as of Q3 2023 after selling out during the quarter.
  • ICA Group Wealth Management sold 200 NanoViricides shares in Q3 2023, an estimated $230.
  • ICA Group Wealth Management first reported a position in NanoViricides in Q4 2022 and held it in 3 quarters.
  • ICA Group Wealth Management's NanoViricides position peaked at $283 in Q4 2022.
  • 30 funds tracked by Wall St. Rank held NanoViricides as of Q3 2023.

Based on ICA Group Wealth Management's 13F filing for Q3 2023, filed 13 Nov 2023.